|
RNF139 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.364800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.594000E-01 |
| Normal-vs-Stage2 |
7.715400E-01 |
| Normal-vs-Stage3 |
4.184000E-01 |
| Normal-vs-Stage4 |
1.922640E-01 |
| Stage1-vs-Stage2 |
2.873000E-01 |
| Stage1-vs-Stage3 |
6.297900E-02 |
| Stage1-vs-Stage4 |
1.014500E-02 |
| Stage2-vs-Stage3 |
6.470200E-01 |
| Stage2-vs-Stage4 |
3.712000E-01 |
| Stage3-vs-Stage4 |
6.768400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.089000E-01 |
| Normal-vs-AfricanAmerican |
3.136000E-01 |
| Normal-vs-Asian |
6.542600E-01 |
| Caucasian-vs-AfricanAmerican |
2.704800E-01 |
| Caucasian-vs-Asian |
6.784400E-01 |
| AfricanAmerican-vs-Asian |
9.839800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.956600E-01 |
| Normal-vs-Female |
8.571800E-01 |
| Male-vs-Female |
3.789400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.410400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.432600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.909000E-01 |
| Normal-vs-Age(81-100Yrs) |
9.955000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.042400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.004400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.260000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.359800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.434800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.898200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.642440E-01 |
| Normal-vs-Grade 2 |
1.605840E-01 |
| Normal-vs-Grade 3 |
1.503170E-01 |
| Normal-vs-Grade 4 |
2.515700E-02 |
| Grade 1-vs-Grade 2 |
6.725200E-01 |
| Grade 1-vs-Grade 3 |
4.581600E-02 |
| Grade 1-vs-Grade 4 |
1.127600E-02 |
| Grade 2-vs-Grade 3 |
5.79170000000184E-05 |
| Grade 2-vs-Grade 4 |
1.72411000000094E-05 |
| Grade 3-vs-Grade 4 |
1.266830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.094000E-01 |
| Normal-vs-ccB subtype |
6.158600E-01 |
| ccA subtype-vs-ccB subtype |
3.119800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.039400E-01 |
| Normal-vs-N1 |
1.772760E-01 |
| N0-vs-N1 |
2.298400E-01 |
|
|
